Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/128558
Title: Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain
Author: Sivera, Rafael
Frasquet, Marina
Lupo, Vincenzo
García-Sobrino, Tania
Blanco-Arias, Patricia
Pardo, Julio
Fernández-Torrón, Roberto
López de Munain, Adolfo
Márquez Infante, Celedonio
Villarreal, Liliana
Carbonell, Pilar
Rojas-Garcia, Ricard
Segovia, Sonia
Illa Sendra, Isabel
Frongia, Anna Lia
Nascimento, Andrés
Ortez, Carlos Ignacio
García-Romero, Mar
Pascual-Pascua, Samuel Ignacio
Pelayo-Negro, Ana Lara
Berciano, José
Guerrero Sola, Antonio
Casasnovas Pons, Carlos
Camacho, Ana
Esteban, Jesús
Chumillas, María José
Barreiro, Marisa
Díaz, Carmen
Palau Martínez, Francesc
Vílchez, Juan Jesús
Espinós, Carmen
Sevilla, Teresa
Keywords: Imatges per ressonància magnètica
Patologia
Fenotip
Mutació (Biologia)
Amiotròfia neural progressiva de Charcot-Marie-Tooth
Espanya
Magnetic resonance imaging
Pathology
Phenotype
Mutation (Biology)
Charcot-Marie-Tooth disease
Spain
Issue Date: 27-Jul-2017
Publisher: Nature Publishing Group
Abstract: Mutations in the GDAP1 gene can cause Charcot-Marie-Tooth disease. These mutations are quite rare in most Western countries but not so in certain regions of Spain or other Mediterranean countries. This cross-sectional retrospective multicenter study analyzed the clinical and genetic characteristics of patients with GDAP1 mutations across Spain. 99 patients were identified, which were distributed across most of Spain, but especially in the Northwest and Mediterranean regions. The most common genotypes were p.R120W (in 81% of patients with autosomal dominant inheritance) and p.Q163X (in 73% of autosomal recessive patients). Patients with recessively inherited mutations had a more severe phenotype, and certain clinical features, like dysphonia or respiratory dysfunction, were exclusively detected in this group. Dominantly inherited mutations had prominent clinical variability regarding severity, including 29% of patients who were asymptomatic. There were minor clinical differences between patients harboring specific mutations but not when grouped according to localization or type of mutation. This is the largest clinical series to date of patients with GDAP1 mutations, and it contributes to define the genetic distribution and genotype-phenotype correlation in this rare form of CMT.
Note: Reproducció del document publicat a: https://doi.org/10.1038/s41598-017-06894-6
It is part of: Scientific Reports, 2017, vol. 7, p. 6677
URI: http://hdl.handle.net/2445/128558
Related resource: https://doi.org/10.1038/s41598-017-06894-6
ISSN: 2045-2322
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
677744.pdf1.38 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons